NasdaqGM - Nasdaq Real Time Price USD

Fractyl Health, Inc. (GUTS)

1.9000
0.0000
(0.00%)
At close: May 30 at 4:00:01 PM EDT
2.0335
+0.13
+(7.03%)
After hours: May 30 at 7:28:25 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
60
93
120
0
0
Cost of Revenue
31
50
77
0
--
Gross Profit
29
43
43
0
--
Operating Expense
96,777
93,574
50,879
49,385
36,928
Operating Income
-96,748
-93,531
-50,836
-49,385
-36,928
Net Non Operating Interest Income Expense
3,551
4,146
1,260
797
-1,442
Other Income Expense
4,090
20,691
-27,515
2,135
-365
Pretax Income
-89,107
-68,694
-77,091
-46,453
-38,735
Net Income Common Stockholders
-89,107
-70,431
-94,271
-63,633
-53,221
Diluted NI Available to Com Stockholders
-89,107
-70,431
-94,271
-63,633
-53,221
Basic EPS
-1.94
-1.62
-1.98
-1.34
-1.12
Diluted EPS
-1.94
-1.62
-1.98
-1.34
-1.12
Basic Average Shares
48,323.6660
43,541.5270
47,607.2010
47,607.2010
47,607.2010
Diluted Average Shares
48,323.6660
43,541.5270
47,607.2010
82,428.3630
47,607.2010
Total Operating Income as Reported
-96,748
-93,531
-50,836
-49,385
-36,928
Total Expenses
96,808
93,624
50,956
49,385
36,928
Net Income from Continuing & Discontinued Operation
-89,107
-68,694
-77,091
-46,453
-38,735
Normalized Income
-97,394
-86,602
-70,297
-46,277
-38,379
Interest Income
3,551
4,146
1,260
797
--
Interest Expense
--
--
--
--
1,442
Net Interest Income
3,551
4,146
1,260
797
-1,442
EBIT
-96,748
-93,531
-50,836
-49,385
-36,928
EBITDA
-95,834
-92,854
-50,550
-48,933
-36,252
Reconciled Cost of Revenue
31
50
77
0
--
Reconciled Depreciation
914
677
286
452
676
Net Income from Continuing Operation Net Minority Interest
-89,107
-68,694
-77,091
-46,453
-38,735
Total Unusual Items Excluding Goodwill
8,287
17,908
-6,794
-176
-356
Total Unusual Items
8,287
17,908
-6,794
-176
-356
Normalized EBITDA
-104,121
-110,762
-43,756
-48,757
-35,896
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/2/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AVBP ArriVent BioPharma, Inc.
21.25
+1.19%
 
VTYX Ventyx Biosciences, Inc.
1.7000
-6.08%
 
FBLG FibroBiologics, Inc.
0.7295
-2.73%
 
TERN Terns Pharmaceuticals, Inc.
3.1100
+0.32%
 
ANRO Alto Neuroscience, Inc.
2.5800
-4.09%
 
GPCR Structure Therapeutics Inc.
21.76
-2.94%
 
CGON CG Oncology, Inc.
25.62
-2.33%
 
AKESF Akeso, Inc.
10.43
-1.42%
 
DSGN Design Therapeutics, Inc.
3.7300
-6.98%
 
CMPX Compass Therapeutics, Inc.
2.1000
-0.94%